Financials
- Market Capitalization 871.25 M
- Employee 90
- Founded 2013
- CEO N/A
- Website www.theravance.com
- Headquarter California, United States
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
7.38
売上高対価格比率
7.59
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2526 | ANNX Annexon, Inc. - common stock | 5.63 USD | -2.93% | -6.01% | +17.29% | +114.07% | 922.43 M USD | ||
| 2535 | GERN Geron Corporation - Common Stock | 1.42 USD | -5.33% | -1.39% | +22.41% | +6.77% | 910.96 M USD | ||
| 2559 | PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 10.92 USD | -13.40% | -5.37% | +5.81% | +20.80% | 870.94 M USD | ||
| 2561 | DSGN Design Therapeutics, Inc. - Common Stock | 13.86 USD | -8.76% | -7.41% | +24.98% | +248.24% | 865.65 M USD |